本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

435.01
-4.9900-1.13%
盘后430.54-4.4700-1.03%18:33 EST
成交量:47.46万
成交额:2.07亿
市值:99.79亿
市盈率:-33.85
高:447.01
开:440.00
低:434.67
收:440.00
52周最高:615.00
52周最低:265.00
股本:2,294.00万
流通股本:1,100.01万
量比:0.83
换手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):-12.8501
每股收益(LYR):-12.8501
净资产收益率:-42.49%
总资产收益率:-16.30%
市净率:16.56
市盈率(LYR):-33.85

数据加载中...

2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]